Tabula Rasa HealthCare Inc (NASDAQ:TRHC) shares were down 6.1% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $31.64 and last traded at $32.25. Approximately 582,097 shares were traded during trading, an increase of 133% from the average daily volume of 249,872 shares. The stock had previously closed at $34.33.
Specifically, CFO Brian W. Adams purchased 5,391 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The shares were acquired at an average cost of $14.23 per share, for a total transaction of $76,713.93. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Growth Fund 1Q Lp Originate sold 684,180 shares of the stock in a transaction that occurred on Monday, December 11th. The stock was sold at an average price of $25.85, for a total value of $17,686,053.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,359,422 shares of company stock worth $37,411,141. Corporate insiders own 45.80% of the company’s stock.
A number of research firms recently commented on TRHC. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $38.00 price target on the stock in a research report on Thursday, January 11th. Citigroup began coverage on Tabula Rasa HealthCare in a research report on Thursday, January 4th. They set a “buy” rating on the stock. BidaskClub upgraded Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research report on Thursday, December 21st. Oppenheimer began coverage on Tabula Rasa HealthCare in a research report on Monday, December 18th. They set an “outperform” rating and a $35.00 price target on the stock. Finally, William Blair began coverage on Tabula Rasa HealthCare in a research report on Monday, December 11th. They set an “outperform” rating on the stock. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $29.78.
A number of large investors have recently bought and sold shares of the business. Hood River Capital Management LLC lifted its holdings in Tabula Rasa HealthCare by 17.1% during the 4th quarter. Hood River Capital Management LLC now owns 883,290 shares of the company’s stock worth $24,776,000 after buying an additional 129,031 shares in the last quarter. Ranger Investment Management L.P. lifted its holdings in Tabula Rasa HealthCare by 896.7% during the 4th quarter. Ranger Investment Management L.P. now owns 777,341 shares of the company’s stock worth $21,804,000 after buying an additional 699,352 shares in the last quarter. BlackRock Inc. lifted its holdings in Tabula Rasa HealthCare by 2.9% during the 4th quarter. BlackRock Inc. now owns 425,027 shares of the company’s stock worth $11,922,000 after buying an additional 12,121 shares in the last quarter. Jennison Associates LLC lifted its holdings in Tabula Rasa HealthCare by 3.5% during the 4th quarter. Jennison Associates LLC now owns 412,387 shares of the company’s stock worth $11,567,000 after buying an additional 13,932 shares in the last quarter. Finally, UBS Asset Management Americas Inc. acquired a new position in Tabula Rasa HealthCare during the 4th quarter worth $9,559,000. 41.58% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: “Tabula Rasa HealthCare (TRHC) Trading Down 6.1% on Insider Selling” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://stocknewstimes.com/2018/02/24/tabula-rasa-healthcare-trhc-trading-down-6-1-on-insider-selling.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.